Researchers at NTNU in Trondheim and Oxford University have discovered an appetite-reducing hormone, which they hope can be used in the fight against type 2 diabetes.
The sensational discovery came about because of the after effects of the operations of morbidly obese people, TV 2 writes. Many of the patients experienced a decline of diabetes after operations, and scientists have now proven that this effect is caused by the appetite-reducing hormone PYY .
The researchers conducted experiments on rats, and these experiments have shown that the medicine that stimulates the production of PYY, can stop type 2 diabetes, one of the world’s most rapidly growing diseases. But first the drug has to be tested on humans.
– The discovery is quite revolutionary, because the number of people who have type 2 diabetes is believed to reach 600 million worldwide in 15 years time, Magnus Kringstadbukta Olsen, who is a PhD student at the Institute of Cancer Research and Molecular Medicine at NTNU, says.
In 2014 422 million people worldwide had diabetes,the research site Gemini writes.
Source: NTB scanpix / Norway Today